Form D · Hedge Fund
Bioaxia Life Sciences Fund LP
New York, NY · CIK 0002085914
Offering snapshot reported Oct 27, 2026 · SEC filing
- Reported sold
- $3.26M Indefinite offering
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Sep 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 6
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2026 | Amendment | $3,260,000 | No comparison | 6 | SEC filing |
| Sep 15, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-557477
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Oct 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Bioaxia Life Sciences Fund Gp Llc | Executive, Promoter |
| N/A Bioaxia Llc | Executive, Promoter |
| Douglas Eby | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
455 10 Th Avenue Ph2 G
New York, NY, 10018
New York, NY, 10018